Quercetagetin was shown to inhibit PIM1 activity in prostate cancer cells [44] and to have antiproliferative activity in cervical, breast, and lung cancer cell lines in a dose-dependent manner [45]. The gene discussed is PIM1; the disease is prostate carcinoma.